AIMS/HYPOTHESIS: Not all obese individuals develop type 2 diabetes. Why some obese individuals retain normal glucose tolerance (NGT) is not well understood. We hypothesise that the biochemical mechanisms that underlie the function of adipose tissue can help explain the difference between obese individuals with NGT and those with type 2 diabetes. METHODS: RNA sequencing was used to analyse the transcriptome of samples extracted from visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) of obese women with NGT or type 2 diabetes who were undergoing bariatric surgery. The gene expression data was analysed by bioinformatic visualisation and statistical analyses techniques. RESULTS: A network-based approach to distinguish obese individuals with NGT from obese individuals with type 2 diabetes identified acetyl-CoA metabolic network downregulation as an important feature in the pathophysiology of type 2 diabetes in obese individuals. In general, genes within two reaction steps of acetyl-CoA were found to be downregulated in the VAT and SAT of individuals with type 2 diabetes. Upon weight loss and amelioration of metabolic abnormalities three months following bariatric surgery, the expression level of these genes recovered to levels seen in individuals with NGT. We report four novel genes associated with type 2 diabetes and recovery upon weight loss: ACAT1 (encoding acetyl-CoA acetyltransferase 1), ACACA (encoding acetyl-CoA carboxylase α), ALDH6A1 (encoding aldehyde dehydrogenase 6 family, member A1) and MTHFD1 (encoding methylenetetrahydrofolate dehydrogenase). CONCLUSIONS/ INTERPRETATION: Downregulation of the acetyl-CoA network in VAT and SAT is an important feature in the pathophysiology of type 2 diabetes in obese individuals. ACAT1, ACACA, ALDH6A1 and MTHFD1 represent novel biomarkers in adipose tissue associated with type 2 diabetes in obese individuals.
AIMS/HYPOTHESIS: Not all obese individuals develop type 2 diabetes. Why some obese individuals retain normal glucose tolerance (NGT) is not well understood. We hypothesise that the biochemical mechanisms that underlie the function of adipose tissue can help explain the difference between obese individuals with NGT and those with type 2 diabetes. METHODS: RNA sequencing was used to analyse the transcriptome of samples extracted from visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT) of obesewomen with NGT or type 2 diabetes who were undergoing bariatric surgery. The gene expression data was analysed by bioinformatic visualisation and statistical analyses techniques. RESULTS: A network-based approach to distinguish obese individuals with NGT from obese individuals with type 2 diabetes identified acetyl-CoA metabolic network downregulation as an important feature in the pathophysiology of type 2 diabetes in obese individuals. In general, genes within two reaction steps of acetyl-CoA were found to be downregulated in the VAT and SAT of individuals with type 2 diabetes. Upon weight loss and amelioration of metabolic abnormalities three months following bariatric surgery, the expression level of these genes recovered to levels seen in individuals with NGT. We report four novel genes associated with type 2 diabetes and recovery upon weight loss: ACAT1 (encoding acetyl-CoA acetyltransferase 1), ACACA (encoding acetyl-CoA carboxylase α), ALDH6A1 (encoding aldehyde dehydrogenase 6 family, member A1) and MTHFD1 (encoding methylenetetrahydrofolate dehydrogenase). CONCLUSIONS/ INTERPRETATION: Downregulation of the acetyl-CoA network in VAT and SAT is an important feature in the pathophysiology of type 2 diabetes in obese individuals. ACAT1, ACACA, ALDH6A1 and MTHFD1 represent novel biomarkers in adipose tissue associated with type 2 diabetes in obese individuals.
Authors: Peter A C 't Hoen; Marc R Friedländer; Jonas Almlöf; Michael Sammeth; Irina Pulyakhina; Seyed Yahya Anvar; Jeroen F J Laros; Henk P J Buermans; Olof Karlberg; Mathias Brännvall; Johan T den Dunnen; Gert-Jan B van Ommen; Ivo G Gut; Roderic Guigó; Xavier Estivill; Ann-Christine Syvänen; Emmanouil T Dermitzakis; Tuuli Lappalainen Journal: Nat Biotechnol Date: 2013-09-15 Impact factor: 54.908
Authors: J Naukkarinen; S Heinonen; A Hakkarainen; J Lundbom; K Vuolteenaho; L Saarinen; S Hautaniemi; A Rodriguez; G Frühbeck; P Pajunen; T Hyötyläinen; M Orešič; E Moilanen; A Suomalainen; N Lundbom; J Kaprio; A Rissanen; K H Pietiläinen Journal: Diabetologia Date: 2013-10-08 Impact factor: 10.122
Authors: Mohammed Qatanani; Yejun Tan; Radu Dobrin; Danielle M Greenawalt; Guanghui Hu; Wenqing Zhao; Jerrold M Olefsky; Dorothy D Sears; Lee M Kaplan; Daniel M Kemp Journal: Diabetes Date: 2012-12-06 Impact factor: 9.461
Authors: Manway Liu; Arthur Liberzon; Sek Won Kong; Weil R Lai; Peter J Park; Isaac S Kohane; Simon Kasif Journal: PLoS Genet Date: 2007-06 Impact factor: 5.917
Authors: Tuuli Lappalainen; Michael Sammeth; Marc R Friedländer; Peter A C 't Hoen; Jean Monlong; Manuel A Rivas; Mar Gonzàlez-Porta; Natalja Kurbatova; Thasso Griebel; Pedro G Ferreira; Matthias Barann; Thomas Wieland; Liliana Greger; Maarten van Iterson; Jonas Almlöf; Paolo Ribeca; Irina Pulyakhina; Daniela Esser; Thomas Giger; Andrew Tikhonov; Marc Sultan; Gabrielle Bertier; Daniel G MacArthur; Monkol Lek; Esther Lizano; Henk P J Buermans; Ismael Padioleau; Thomas Schwarzmayr; Olof Karlberg; Halit Ongen; Helena Kilpinen; Sergi Beltran; Marta Gut; Katja Kahlem; Vyacheslav Amstislavskiy; Oliver Stegle; Matti Pirinen; Stephen B Montgomery; Peter Donnelly; Mark I McCarthy; Paul Flicek; Tim M Strom; Hans Lehrach; Stefan Schreiber; Ralf Sudbrak; Angel Carracedo; Stylianos E Antonarakis; Robert Häsler; Ann-Christine Syvänen; Gert-Jan van Ommen; Alvis Brazma; Thomas Meitinger; Philip Rosenstiel; Roderic Guigó; Ivo G Gut; Xavier Estivill; Emmanouil T Dermitzakis Journal: Nature Date: 2013-09-15 Impact factor: 49.962
Authors: Natalia Moreno-Castellanos; Rocío Guzmán-Ruiz; David A Cano; Ainara Madrazo-Atutxa; Juan R Peinado; Jose L Pereira-Cunill; Pedro Pablo García-Luna; Salvador Morales-Conde; Maria Socas-Macias; Rafael Vázquez-Martínez; Alfonso Leal-Cerro; María M Malagón Journal: Obes Surg Date: 2016-08 Impact factor: 4.129
Authors: Manik Vohra; Prabha Adhikari; Sydney C D' Souza; Shivashankar K Nagri; Shashikiran Umakanth; Kapaettu Satyamoorthy; Padmalatha S Rai Journal: Lab Invest Date: 2020-04-01 Impact factor: 5.662
Authors: Mattijs M Heemskerk; Martin Giera; Fatiha El Bouazzaoui; Mirjam A Lips; Hanno Pijl; Ko Willems van Dijk; Vanessa van Harmelen Journal: Nutrients Date: 2015-09-11 Impact factor: 5.717
Authors: Cagri Camsari; Joseph K Folger; Devin McGee; Steven J Bursian; Hongbing Wang; Jason G Knott; George W Smith Journal: Environ Health Perspect Date: 2016-11-04 Impact factor: 9.031
Authors: Samar H K Tareen; Michiel E Adriaens; Ilja C W Arts; Theo M de Kok; Roel G Vink; Nadia J T Roumans; Marleen A van Baak; Edwin C M Mariman; Chris T Evelo; Martina Kutmon Journal: Genes (Basel) Date: 2018-10-29 Impact factor: 4.096